ACTRN12624000742572尚未招募Unknown
Evaluation of efficacy of an invisible bite advancement device (IBAD), a removable functional appliance, and a rigid fixed functional appliance for the treatment of Class II malocclusion in adolescents: A single-centre randomized controlled trial
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 10 Years 至 14 Years（—）
- 性别
- All
入选标准
- •1. Sex: Male, female
- •2. Age range: Active pubertal growth evaluated by cervical vertebral maturation stages (CVMS). CVMS up to 3-4
- •3. Angle’s Class II division 1 malocclusion
- •4. ANB angle, equal to or more than 3.5° (The ANB angle measures the relative anteroposterior position between the maxilla and mandible. In normal individuals, the ANB angle is 2° ± 2°)
- •5. Overjet, equal to or more than 5 mm. The overjet is the extent of horizontal (anterioposterior) overlap of the maxillary central incisors over the mandibular central incisors (normal amount of overlap is between 2 and 4mm)
- •6. Mild-moderate dental crowding (1-4 mm, 4-7 mm respectively including the curve of Spee
排除标准
- •1. Syndromic individuals (including cleft lip and palate)
- •2. Crossbite, severe crowding, hypodontia.
- •3. Temporomandibular joint disorder signs and symptoms
- •4. Previous Orthodontic treatment
研究者
相似试验
尚未招募
2 期
Comparing two methods to correct deep bite, using small metal anterior bite block and curved stainless steel wire.CTRI/2023/04/051322DR AKHILA T
Unknown
Unknown
Open bite treatment with fixed palatal crib with and without myofunctional therapy: a randomized clinical trialRBR-109j9jwwFaculdade de Odontologia de Bauru - Universidade de São Paulo
进行中（未招募）
不适用
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments.EUCTR2011-001493-25-ATovo Nordisk A/S420
进行中（未招募）
不适用
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments.Type 2 diabetesMedDRA version: 14.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001493-25-DEovo Nordisk A/S420
进行中（未招募）
不适用
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments.Diabetes tipo 2MedDRA version: 13.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001493-25-ESovo Nordisk A/S420